Table 1 Distribution of qualitative and quantitative variables among the 9792 male and female subjects, Fasa PERSIAN cohort study, 2014–2019

Age (years)

48.74 ± 9.56

48.64 ± 9.53

48.86 ± 9.61

0.26

DM

12.4%

16%

7.9%

 < 0.0001*

HTN

20.3%

27.2%

11.6%

 < 0.0001*

DBP (mmHg)

74.71 ± 11.94

74.90 ± 12.05

74.47 ± 11.79

0.07

SBP (mmHg)

111.49 ± 18.46

112.09 ± 19.15

110.72 ± 17.51

 < 0.0001*

MAP (mmHg)

86.96 ± 13.42

87.29 ± 13.74

86.55 ± 13.00

0.006*

BMI (Kg/m²)

25.69 ± 4.82

26.85 ± 4.81

24.21 ± 4.41

 < 0.0001*

MET (ml/kg/min)

41.41 ± 11.25

38.43 ± 6.72

45.22 ± 14.31

 < 0.0001*

WBC (count/µl)

6.36 ± 1.34

6.32 ± 1.32

6.41 ± 1.36

0.002*

FBS (mg/dl)

92.70 ± 29.59

94.56 ± 33.05

90.33 ± 24.28

 < 0.0001*

Triglyceride (mg/dl)

131.57 ± 82.19

128.31 ± 74.23

135.73 ± 91.18

 < 0.0001*

Cholesterol (mg/dl)

185.28 ± 39.13

190.28 ± 39.44

178.90 ± 37.78

 < 0.0001*

AlkP (IU/l)

209.53 ± 71.65

208.24 ± 75.61

211.17 ± 66.23

0.04*

HDL (mg/dl)

51.20 ± 15.96

54.17 ± 16.41

47.40 ± 14.51

 < 0.0001*

LDL (mg/dl)

107.74 ± 32.82

110.41 ± 33.56

104.33 ± 31.53

 < 0.0001*

GGT (IU/l)

22.80 ± 21.45

20.43 ± 20.06

25.81 ± 22.75

 < 0.0001*

Energy intake (kcal/day)

2929.9 ± 1148.2

2819.9 ± 1113.5

3070.4 ± 1176.39

 < 0.0001*

FLI

39.73 ± 27.72

43.49 ± 27.62

34.94 ± 27.11

 < 0.0001*

DII

-0.30 ± 2.05

-0.26 ± 2.21

-0.35 ± 1.83

0.03*

HT

28.1%

27.4%

29.1%

0.06

HC

32.3%

36.6%

26.8%

 < 0.0001*

Opium consumption

22%

1.8%

47.7%

 < 0.0001*

Smoking

25.9%

5%

52.5%

 < 0.0001*

NAFLD

26.9%

30.9%

21.8%

 < 0.0001*

Total count

9792

5494

4298

-